Scimago Lab
powered by Scopus
Formerly the IP & Science
business of Thomson Reuters


eISSN: 1643-3750

Gabapentin in the treatment of dementia-associated nocturnal agitation

Jitka Buskova, Petr Busek, Sona Nevsimalova

Med Sci Monit 2011; 17(12): CS149-151

DOI: 10.12659/MSM.882114

Published: 2011-12-01

Background:    Nocturnal sleep of patients suffering from various forms of dementia is often impaired by nocturnal agitation or nocturnal wandering. Anticonvulsives such as carbamazepine or valproate are reported to have some therapeutic efficacy, but there is little information about other drugs suitable for treatment of this condition.
    Case Report:    Our patient, a 77-year-old Czech woman with incipient vascular dementia, received gabapentin 400mg at bedtime for 6 months and showed convincing improvement.
    Conclusions:    Gabapentin was very effective in treating nocturnal agitation.

Keywords: Female, Dementia - drug therapy, Darkness, Cyclohexanecarboxylic Acids - therapeutic use, Anti-Anxiety Agents - therapeutic use, Aged, Amines - therapeutic use, Humans, Psychomotor Agitation - drug therapy, gamma-Aminobutyric Acid - therapeutic use